The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hydronephrosis Treatment Market Research Report 2025
Synopsis
Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney.
The global Hydronephrosis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hydronephrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydronephrosis Treatment.
Report Scope
The Hydronephrosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hydronephrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydronephrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NephroGenex
PHRAXIS
Allergan
Amgen
Anthem Group
Sanofi
Novartis
Segment by Type
Surgical Treatment
Drug Treatment
Segment by Application
Hospital
Clinic
Ambulatory Surgery Centre
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydronephrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney.
The global Hydronephrosis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hydronephrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydronephrosis Treatment.
Report Scope
The Hydronephrosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hydronephrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydronephrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NephroGenex
PHRAXIS
Allergan
Amgen
Anthem Group
Sanofi
Novartis
Segment by Type
Surgical Treatment
Drug Treatment
Segment by Application
Hospital
Clinic
Ambulatory Surgery Centre
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydronephrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hydronephrosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgical Treatment
1.2.3 Drug Treatment
1.3 Market by Application
1.3.1 Global Hydronephrosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Ambulatory Surgery Centre
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hydronephrosis Treatment Market Perspective (2019-2030)
2.2 Hydronephrosis Treatment Growth Trends by Region
2.2.1 Global Hydronephrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hydronephrosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hydronephrosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hydronephrosis Treatment Market Dynamics
2.3.1 Hydronephrosis Treatment Industry Trends
2.3.2 Hydronephrosis Treatment Market Drivers
2.3.3 Hydronephrosis Treatment Market Challenges
2.3.4 Hydronephrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hydronephrosis Treatment Players by Revenue
3.1.1 Global Top Hydronephrosis Treatment Players by Revenue (2019-2024)
3.1.2 Global Hydronephrosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hydronephrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hydronephrosis Treatment Revenue
3.4 Global Hydronephrosis Treatment Market Concentration Ratio
3.4.1 Global Hydronephrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hydronephrosis Treatment Revenue in 2023
3.5 Hydronephrosis Treatment Key Players Head office and Area Served
3.6 Key Players Hydronephrosis Treatment Product Solution and Service
3.7 Date of Enter into Hydronephrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hydronephrosis Treatment Breakdown Data by Type
4.1 Global Hydronephrosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hydronephrosis Treatment Forecasted Market Size by Type (2025-2030)
5 Hydronephrosis Treatment Breakdown Data by Application
5.1 Global Hydronephrosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hydronephrosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hydronephrosis Treatment Market Size (2019-2030)
6.2 North America Hydronephrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hydronephrosis Treatment Market Size by Country (2019-2024)
6.4 North America Hydronephrosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hydronephrosis Treatment Market Size (2019-2030)
7.2 Europe Hydronephrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hydronephrosis Treatment Market Size by Country (2019-2024)
7.4 Europe Hydronephrosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hydronephrosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Hydronephrosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hydronephrosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Hydronephrosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hydronephrosis Treatment Market Size (2019-2030)
9.2 Latin America Hydronephrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hydronephrosis Treatment Market Size by Country (2019-2024)
9.4 Latin America Hydronephrosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hydronephrosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Hydronephrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hydronephrosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Hydronephrosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NephroGenex
11.1.1 NephroGenex Company Detail
11.1.2 NephroGenex Business Overview
11.1.3 NephroGenex Hydronephrosis Treatment Introduction
11.1.4 NephroGenex Revenue in Hydronephrosis Treatment Business (2019-2024)
11.1.5 NephroGenex Recent Development
11.2 PHRAXIS
11.2.1 PHRAXIS Company Detail
11.2.2 PHRAXIS Business Overview
11.2.3 PHRAXIS Hydronephrosis Treatment Introduction
11.2.4 PHRAXIS Revenue in Hydronephrosis Treatment Business (2019-2024)
11.2.5 PHRAXIS Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Hydronephrosis Treatment Introduction
11.3.4 Allergan Revenue in Hydronephrosis Treatment Business (2019-2024)
11.3.5 Allergan Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Hydronephrosis Treatment Introduction
11.4.4 Amgen Revenue in Hydronephrosis Treatment Business (2019-2024)
11.4.5 Amgen Recent Development
11.5 Anthem Group
11.5.1 Anthem Group Company Detail
11.5.2 Anthem Group Business Overview
11.5.3 Anthem Group Hydronephrosis Treatment Introduction
11.5.4 Anthem Group Revenue in Hydronephrosis Treatment Business (2019-2024)
11.5.5 Anthem Group Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Hydronephrosis Treatment Introduction
11.6.4 Sanofi Revenue in Hydronephrosis Treatment Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Hydronephrosis Treatment Introduction
11.7.4 Novartis Revenue in Hydronephrosis Treatment Business (2019-2024)
11.7.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hydronephrosis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgical Treatment
Table 3. Key Players of Drug Treatment
Table 4. Global Hydronephrosis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Hydronephrosis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hydronephrosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Hydronephrosis Treatment Market Share by Region (2019-2024)
Table 8. Global Hydronephrosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Hydronephrosis Treatment Market Share by Region (2025-2030)
Table 10. Hydronephrosis Treatment Market Trends
Table 11. Hydronephrosis Treatment Market Drivers
Table 12. Hydronephrosis Treatment Market Challenges
Table 13. Hydronephrosis Treatment Market Restraints
Table 14. Global Hydronephrosis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Hydronephrosis Treatment Market Share by Players (2019-2024)
Table 16. Global Top Hydronephrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydronephrosis Treatment as of 2023)
Table 17. Ranking of Global Top Hydronephrosis Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Hydronephrosis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hydronephrosis Treatment Product Solution and Service
Table 21. Date of Enter into Hydronephrosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hydronephrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Hydronephrosis Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Hydronephrosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Hydronephrosis Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Hydronephrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Hydronephrosis Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Hydronephrosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Hydronephrosis Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Hydronephrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Hydronephrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Hydronephrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Hydronephrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Hydronephrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Hydronephrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Hydronephrosis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Hydronephrosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Hydronephrosis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hydronephrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Hydronephrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Hydronephrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Hydronephrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Hydronephrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Hydronephrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. NephroGenex Company Detail
Table 47. NephroGenex Business Overview
Table 48. NephroGenex Hydronephrosis Treatment Product
Table 49. NephroGenex Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 50. NephroGenex Recent Development
Table 51. PHRAXIS Company Detail
Table 52. PHRAXIS Business Overview
Table 53. PHRAXIS Hydronephrosis Treatment Product
Table 54. PHRAXIS Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 55. PHRAXIS Recent Development
Table 56. Allergan Company Detail
Table 57. Allergan Business Overview
Table 58. Allergan Hydronephrosis Treatment Product
Table 59. Allergan Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 60. Allergan Recent Development
Table 61. Amgen Company Detail
Table 62. Amgen Business Overview
Table 63. Amgen Hydronephrosis Treatment Product
Table 64. Amgen Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. Anthem Group Company Detail
Table 67. Anthem Group Business Overview
Table 68. Anthem Group Hydronephrosis Treatment Product
Table 69. Anthem Group Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 70. Anthem Group Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Hydronephrosis Treatment Product
Table 74. Sanofi Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Hydronephrosis Treatment Product
Table 79. Novartis Revenue in Hydronephrosis Treatment Business (2019-2024) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hydronephrosis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hydronephrosis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Surgical Treatment Features
Figure 4. Drug Treatment Features
Figure 5. Global Hydronephrosis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Hydronephrosis Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Ambulatory Surgery Centre Case Studies
Figure 10. Hydronephrosis Treatment Report Years Considered
Figure 11. Global Hydronephrosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Hydronephrosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Hydronephrosis Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Hydronephrosis Treatment Market Share by Players in 2023
Figure 15. Global Top Hydronephrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydronephrosis Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Hydronephrosis Treatment Revenue in 2023
Figure 17. North America Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Hydronephrosis Treatment Market Share by Country (2019-2030)
Figure 19. United States Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hydronephrosis Treatment Market Share by Country (2019-2030)
Figure 23. Germany Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hydronephrosis Treatment Market Share by Region (2019-2030)
Figure 31. China Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hydronephrosis Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hydronephrosis Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Hydronephrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. NephroGenex Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 46. PHRAXIS Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 47. Allergan Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 48. Amgen Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 49. Anthem Group Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 50. Sanofi Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Hydronephrosis Treatment Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
